Condition
Craniofacial Pain
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Unknown2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT04930887Phase 2RecruitingPrimary
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
NCT06724029Recruiting
Neurosurgical Outcome Network
NCT05414695Not ApplicableUnknown
Effect of Acupuncture on Craniomandibular Pain of Myofascial Origin.
NCT05136625Not ApplicableUnknown
Sphenopalatine Ganglion Block and Pain Management in Neurosurgery
Showing all 4 trials